<DOC>
	<DOCNO>NCT01634126</DOCNO>
	<brief_summary>Colorectal cancer ( CRC ) lead cause cancer death United States . Screening CRC reduces CRC mortality , yet rate screen United States remain low . Fecal occult blood testing ( FOBT ) establish positive balance benefit risk , least expensive , preferred method nearly half patient . A new fecal screening test , fecal immunochemical test ( FIT ) , offer significant improvement FOBT . It easy use sensitive detecting CRC precancerous adenoma FOBT . The OC-Micro FIT particular interest highly sensitive specific FIT test approve US process automated manner . Thus , OC-Micro optimal method use mass screening program improve community CRC-screening rate . However , prior study OC-Micro suffer several limitation : conduct population optimal assess screen performance average risk patient U.S. study clearly establish optimal number sample require cut-points test positivity . Therefore , overall goal MY-FIT capitalize highly integrated extensive electronic medical record system study site collect two separate set data , synthesize , provide thorough picture comparative patient adherence , sensitivity , specificity , cost different protocol use OC-Micro FIT . Specifically , among KPNW member age 50-75 average risk colorectal cancer ( CRC ) due CRC screening ( n=78,000 ) , investigator propose : 1 . Compare sensitivity , specificity , positive predictive value , negative predictive value colorectal cancer advance adenoma ( advanced neoplasia ) single-sample FIT ( 1-FIT ) two-sample FIT ( 2-FIT ) use vary cut point positive test ( n=2100 ) . 2 . Compare patient adherence completion 1-FIT versus 2-FIT protocol ( n=3000 ) . 3 . Assess compare cost per screen 1-FIT versus 2-FIT protocol , cost per advanced neoplasia detect 1-FIT versus 2-FIT protocol ( use vary cut point positive test ) ( n=78,000 ) . Answering question provide much-needed strong evidence base best-practice , cost-effective method use OC-Micro FIT screen CRC general U.S. population .</brief_summary>
	<brief_title>Maximizing Yield Fecal Immunochemical Test Colorectal Cancer Screening</brief_title>
	<detailed_description />
	<mesh_term>Colorectal Neoplasms</mesh_term>
	<criteria>Eligible standard KPNW automate telephonic colorectal cancer screen reminder indicate call wish screen FIT . Kaiser Permanente member less 1 year . Currently Kaiser Permanente Center Health Research Do Not Call list .</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>Colon</keyword>
	<keyword>Rectal</keyword>
	<keyword>Cancer</keyword>
	<keyword>Screening</keyword>
	<keyword>FIT</keyword>
	<keyword>Fecal</keyword>
</DOC>